admin
February 7, 2017
Resources

eConsent comes of age

FDA guidelines published in December on the use of electronic informed consent (eConsent) in clinical trials have given fresh encouragement to sponsors to consider it over traditional, paper-based methods. In the first of two podcasts on the topic, Tudor Reilly Health founder Peter Coë talks to Kahmen Lai about the benefits eConsent can bring and why the time is right for the industry to adopt it.

Recommended

TEDMED goes back to basics

Read More

Failure a necessary part of Alzheimer's success

Read More